Analyzing the effect of serum uric acid reduction using Allopurinol on vitamin D levels in hemodialysis patients

Not Applicable

• Conditions: Hemodialysis patients.; Extracorporeal dialysis; Dialysis (renal) NOS

• Registration Number: IRCT2015041721803N1
• Lead Sponsor: Vice chancellor for research center of Shahrekord University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 92

Inclusion Criteria

Hemodialysis patients; ESRD; Asymptomatic hyperuricemia;
Exclusion criteria: Taking Uric acid reducting agents; Taking vitamin D supplements;

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Vitamin D level. Timepoint: Before and after hyperuricemia treatment. Method of measurement: 25OHD serum level immunoassey.